
How cross-functional commercialization teams can hone their role within clinical management pathways, communicate value to all stakeholders, achieve excellence in evidence generation, and maximize the opportunities of digital technologies
Richard Ogborne is a Partner at Vintura, which provides strategy consultancy to pharma and healthcare providers that are embracing transformation. Based in the UK, Richard is a specialist in commercialization strategy; commercial evaluations and due diligence; strategic analytics and forecasting; brand performance management; lifecycle management strategy; pre-launch planning; competitive intelligence and market research.
Richard’s therapy area expertise includes cardiovascular and metabolic disease, renal disease, oncology and dermatology. Richard holds a PhD in cardiovascular disease from Cambridge University, an MBA from The Open University. He is a Chartered Biologist and a Member of the Royal Society of Biology.
Email: [email protected]